Actual Medicinal Product (AMP) Accuretic 10mg/12.5mg tablets (Mawdsley-Brooks & Company Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible_special_measures logo There are concerns about stability and/or there is a lack of stability data available. These medicines can theoretically be used in MCAs, although use is likely to be off-label.  Mitigation measures may need to be considered.  Keep medicines in MCAs for the shortest time necessary.  Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed). Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices. Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.
Notes

Store in tightly closed containers and protect from moisture.

Provenance

This compatibility recommendation is derived from Accuretic 10mg/12.5mg tablets (Pfizer Ltd).

Generic
Quinapril + Hydrochlorothiazide
Formulation
Quinapril 10mg / Hydrochlorothiazide 12.5mg tablets
  • Quinapril + Hydrochlorothiazide
    • Quinapril 10mg / Hydrochlorothiazide 12.5mg tablets

      • Accuretic 10mg/12.5mg tablets (Mawdsley-Brooks & Company Ltd)